Navigation Links
Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
Date:11/23/2011

SAN DIEGO, Nov. 23, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present at the Piper Jaffray 23rd Annual Health Care Conference on Wednesday, November 30, 2011, at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) at The New York Palace in New York City. Jack Lief, Arena's President and Chief Executive Officer, and Craig M. Audet, Arena's Vice President, Global Regulatory Affairs, are scheduled to provide a corporate overview.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate is intended for weight management.

Arena Pharmaceuticals® and Arena® are registered service marks of the company.

Forward-Looking Statements Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the therapeutic indication of Arena's most advanced drug candidate and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protec
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- TWi Pharmaceuticals, Inc. (4180.TT) today announced that it ... Food and Drug Administration (FDA) on its Abbreviated ... oral suspension, the generic equivalent to Par Pharmaceutical,s ... Hatch Waxman rules, it will be entitled to ... the pre-launch preparation of the generic drug.  However, ...
(Date:8/27/2014)... About 8 million Americans have peripheral arterial ... fatty plaque in the arteries, according to recent statistics. ... in incidences of diabetes and obesity, the Society ... Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... residents and fellows will be able to gain state-of-the-art ...
(Date:8/27/2014)... --  Los Angeles orthodontics expert, Dr. Isaac ... want to make their treatment even faster. With this ... patients have a powerful tool to use as they ... by most patients with all types of braces, letting ... AcceleDent® Aura system for a few minutes each day. ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that Chengxuan, a ... Chairman and Chief Executive Officer of the Company, informed ... American Depositary Shares ("ADSs") in the open market on ...
... of Disabled Adults and Children (FODAC) has partnered with Invacare ... of equipment and supplies to Joplin, Missouri. A massive F5 ... 2011, leaving much of the city in ruins. FODAC, with ... supply shipment to Joplin within 24 hours of the disaster. ...
Cached Medicine Technology:China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 3
(Date:8/27/2014)... 2014 DiaSorin has announced that their ... Dihydroxyvitamin D,” will feature guest speaker Dr. Gregory A. ... for Health and Healing Integrative Medicine. Dr. Plotnikoff serves ... Institute for Health and Healing and as Senior Consultant, ... Minnesota. He also serves as a co-editor of the ...
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer and ... bodycon dresses . The company has rich experience in ... items in stock and ready to ship: celebrity bodycon ... sweater dresses and so forth. All of them are ... “We are proud to announce the new collection of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Taking its popular ... Steele Creek YMCA will host its largest crowd ... on Saturday, September 13 at YMCA Camp Thunderbird . ... race divisions: adult, youth and teams. Within each division, ... to their physical limit - for a worthy cause. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Today, Zane ... webinar on compliance tips for administering a premium reimbursement ... reform in full effect, compliance is top of mind ... transition to individual health insurance and premium reimbursement, there ... , In the 35 minute webinar, Zane Benefits President, ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s ... pioneer runner, Kathrine Switzer, most noted for her brave running ... a line of women’s running clothes that unites the history ... 261 Fearless Movement. , “It is such an ... DeBoom. “Kathrine is the original Skirt – she stood ...
Breaking Medicine News(10 mins):Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2
... Oct. 8 Plexus Systems, Inc.,provider of ... today announced a set of enhancements for ... integrated program that will,provide enterprise-wide compliance with ... regulations mandated by the U.S. Food and ...
... LISBON, Portugal and NEW YORK, Oct. ... Hopkins University scientists the most prestigious,vision award ... combating blindness, the,Antonio Champalimaud Foundation continued its ... of its 300,000-square-foot research,facility. The Champalimaud Foundation ...
... be able to share information collected from many thousands of ... Australian National University in Canberra today. , The ANU node ... the John Curtin School of Medical Research, Garran Road, ANU ... to attend for a demonstration of the Grid and interviews. ...
... gaps exist between states, and between poor, middle- and ... News) -- For American children, the state they live ... determine how healthy they are, a new survey shows. ... are in less than optimal health, according to the ...
... service for its smartTOUCH(R),product line, JERICHO, N.Y., ... today announced that it has signed a three ... Mr.,Handyman, to provide its customers professional installation and,programming ... door openers, door locks, thermostats, mailboxes and more., ...
... Cleared for,Patients Who Have Not Benefited From Prior ... Neuronetics, Inc., a,privately-held medical device company and a ... the U.S. Food and Drug Administration,(FDA) has cleared ... the treatment of depression. NeuroStar TMS Therapy(R) is,specifically ...
Cached Medicine News:Health News:Plexus Online Enhances Functions for Medical Device Manufacturing Regulatory Compliance 2Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 2Health News:World Renowned Champalimaud Foundation Extends its Mission with Groundbreaking for Cutting-Edge Research Center 3Health News:Medical data 'Internet' goes live, boosts research 2Health News:Family Income Impacts Children's Health 2Health News:Family Income Impacts Children's Health 3Health News:Family Income Impacts Children's Health 4Health News:Family Income Impacts Children's Health 5Health News:bioMETRX Teams Up With Mr. Handyman 2Health News:bioMETRX Teams Up With Mr. Handyman 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 2Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 4Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 5
... Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme ... the qualitative presumptive (firststep) detection of total ... serum. This ELISA should only be used ... are consistent with Lyme disease. Equivocal or ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Medicine Products: